REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 55 filers reported holding REPLIMUNE GROUP INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $225 | +94.0% | 12,900 | +200.0% | 0.00% | -100.0% |
| Q4 2022 | $116 | -99.8% | 4,300 | 0.0% | 0.00% | – |
| Q3 2022 | $74,000 | -1.3% | 4,300 | 0.0% | 0.00% | – |
| Q2 2022 | $75,000 | +2.7% | 4,300 | 0.0% | 0.00% | – |
| Q1 2022 | $73,000 | -37.1% | 4,300 | 0.0% | 0.00% | – |
| Q4 2021 | $116,000 | -8.7% | 4,300 | 0.0% | 0.00% | – |
| Q3 2021 | $127,000 | -49.0% | 4,300 | -33.8% | 0.00% | -100.0% |
| Q2 2021 | $249,000 | +38.3% | 6,500 | +10.2% | 0.00% | 0.0% |
| Q1 2021 | $180,000 | -29.4% | 5,900 | -11.9% | 0.00% | 0.0% |
| Q4 2020 | $255,000 | +311.3% | 6,700 | +148.1% | 0.00% | – |
| Q3 2020 | $62,000 | -7.5% | 2,700 | 0.0% | 0.00% | – |
| Q2 2020 | $67,000 | +235.0% | 2,700 | +28.6% | 0.00% | – |
| Q1 2020 | $20,000 | -33.3% | 2,100 | 0.0% | 0.00% | – |
| Q4 2019 | $30,000 | -48.3% | 2,100 | -50.0% | 0.00% | – |
| Q3 2019 | $58,000 | +93.3% | 4,200 | +100.0% | 0.00% | – |
| Q2 2019 | $30,000 | -3.2% | 2,100 | 0.0% | 0.00% | – |
| Q1 2019 | $31,000 | +47.6% | 2,100 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -36.4% | 2,100 | 0.0% | 0.00% | – |
| Q3 2018 | $33,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,050,187 | $53,866,302 | 35.13% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $37,055,978 | 5.02% |
| Redmile Group, LLC | 3,811,988 | $67,319,708 | 2.92% |
| Nan Fung Group Holdings Ltd | 189,339 | $3,343,727 | 2.28% |
| Altium Capital Management LP | 148,000 | $2,613,680 | 1.45% |
| Integral Health Asset Management, LLC | 395,000 | $6,975,700 | 1.40% |
| BVF INC/IL | 2,143,036 | $37,846,016 | 1.38% |
| Resolute Capital Asset Partners LLC | 82,500 | $1,457 | 1.06% |
| SECTORAL ASSET MANAGEMENT INC | 262,200 | $4,630,452 | 0.89% |
| Frazier Life Sciences Management, L.P. | 686,762 | $12,128,217 | 0.88% |